Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement
Wilson I. Gonsalves(Mayo Clinic in Arizona), Vivek Roy(Jacksonville College), Jeremy T. Larsen(City of Hope), P. Leif Bergsagel(Mayo Clinic in Arizona), David Dingli, Francis K. Buadi, Morie A. Gertz(Medical University of South Carolina), Taimur Sher(Mayo Clinic in Florida), Nelson Leung(WinnMed), A. Keith Stewart(Princess Margaret Hospital), Angela Mayo(Mayo Clinic in Arizona), Robert A. Kyle(Mayo Clinic), Shaji Kumar(Mayo Clinic), Craig B. Reeder(Mayo Clinic in Arizona), Ronald S. Go(Mayo Clinic), Prashant Kapoor, Amie Fonder, Yi L. Hwa, Sikander Ailawadhi(Jacksonville College), Stephen J. Russell(University of Minnesota Rochester), Rahma Warsame, S. Vincent Rajkumar(WinnMed), Taxiarchis Kourelis(Mayo Clinic in Arizona), Martha Q. Lacy(Mayo Clinic), Eli Muchtar(Mayo Clinic), William J. Hogan(Mayo Clinic), Yi Lin, John A. Lust, Miriam Hobbs, S. R. Hayman(Mayo Clinic), Asher A Chanan Khan(WinnMed), Angela Dispenzieri(Mayo Clinic), Stephen R. Zeldenrust(Mayo Clinic), Rafaël Fonseca(Mayo Clinic in Arizona)
Cited by 116
Related Papers
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2019|1.7k